148 related articles for article (PubMed ID: 23975519)
1. Are regimens containing rituximab effective in the initial treatment of Epstein-Barr virus-positive natural killer cell lymphoproliferative disease-associated hemophagocytic lymphohistiocytosis?
Imashuku S; Kudo N; Kubo K; Yachie A
Int J Hematol; 2013 Sep; 98(3):375-7. PubMed ID: 23975519
[No Abstract] [Full Text] [Related]
2. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.
Serrate C; Silva-Moreno M; Dartigues P; Poujol-Robert A; Sokol H; Gorin NC; Coppo P
Inflamm Bowel Dis; 2009 Oct; 15(10):1449-51. PubMed ID: 19177429
[No Abstract] [Full Text] [Related]
4. Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
Yatsushiro Y; Nishikawa T; Saito A; Nakazawa Y; Imadome KI; Nakagawa S; Kodama Y; Okamoto Y; Kanegane H; Kawano Y
J Pediatr Hematol Oncol; 2019 Jan; 41(1):e44-e46. PubMed ID: 29324572
[TBL] [Abstract][Full Text] [Related]
5. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.
Bode SF; Ammann S; Al-Herz W; Bataneant M; Dvorak CC; Gehring S; Gennery A; Gilmour KC; Gonzalez-Granado LI; Groß-Wieltsch U; Ifversen M; Lingman-Framme J; Matthes-Martin S; Mesters R; Meyts I; van Montfrans JM; Pachlopnik Schmid J; Pai SY; Soler-Palacin P; Schuermann U; Schuster V; Seidel MG; Speckmann C; Stepensky P; Sykora KW; Tesi B; Vraetz T; Waruiru C; Bryceson YT; Moshous D; Lehmberg K; Jordan MB; Ehl S;
Haematologica; 2015 Jul; 100(7):978-88. PubMed ID: 26022711
[TBL] [Abstract][Full Text] [Related]
6. Treatment of rare co-occurrence of Epstein-Barr virus-driven post-transplant lymphoproliferative disorder and hemophagocytic lymphohistiocytosis after allogeneic stem cell transplantation.
Weber T; Wickenhauser C; Monecke A; Gläser C; Stadler M; Desole M; Ligeti K; Behrmann C; Müller-Tidow C; Müller LP
Transpl Infect Dis; 2014 Dec; 16(6):988-92. PubMed ID: 25179757
[TBL] [Abstract][Full Text] [Related]
7. Two-faced haemophagocytic lymphohistiocytosis: comparative review of two cases of adult haemophagocytic lymphohistiocytosis.
Mayson E; Saverimuttu J; Warburton P
Intern Med J; 2014 Feb; 44(2):198-201. PubMed ID: 24528817
[TBL] [Abstract][Full Text] [Related]
8. [Hemophagocytic lymphohistiocytosis].
Imamura Y
Rinsho Ketsueki; 2014 Feb; 55(2):223-33. PubMed ID: 24598190
[No Abstract] [Full Text] [Related]
9. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
[TBL] [Abstract][Full Text] [Related]
10. Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant.
Bonney DK; Htwe EE; Turner A; Kelsey A; Shabani A; Hughes S; Hughes I; Wynn RF
Pediatr Blood Cancer; 2012 Mar; 58(3):459-61. PubMed ID: 21584931
[TBL] [Abstract][Full Text] [Related]
11. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.
Balamuth NJ; Nichols KE; Paessler M; Teachey DT
J Pediatr Hematol Oncol; 2007 Aug; 29(8):569-73. PubMed ID: 17762500
[TBL] [Abstract][Full Text] [Related]
12. Familial haemophagocytic lymphohistiocytosis: Australian experience and perspectives.
Voskoboinik I; Thia K; Trapani JA
Intern Med J; 2014 Aug; 44(8):826-7. PubMed ID: 25081055
[No Abstract] [Full Text] [Related]
13. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
14. A case of EBV driven haemophagocytic lymphohistiocytosis complicating a teenage Crohn's disease patient on azathioprine, successfully treated with rituximab.
Fitzgerald MP; Armstrong L; Hague R; Russell RK
J Crohns Colitis; 2013 May; 7(4):314-7. PubMed ID: 22640698
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.
Maldonado NI; Cabanillas F; Jaffe ES; Raffeld M; Lozada L
J Clin Oncol; 2011 Aug; 29(22):e658-60. PubMed ID: 21646613
[No Abstract] [Full Text] [Related]
16. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
[TBL] [Abstract][Full Text] [Related]
17. Refractory hemophagocytic syndrome in systemic lupus erythematosus successfully treated with intermittent intravenous cyclophosphamide: three case reports and literature review.
Ueda Y; Yamashita H; Takahashi Y; Kaneko H; Kano T; Mimori A
Clin Rheumatol; 2014 Feb; 33(2):281-6. PubMed ID: 24343456
[TBL] [Abstract][Full Text] [Related]
18. Prolonged reactivation of cytomegalovirus infection following successful rituximab therapy for Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder.
Hirokawa M; Kawabata Y; Fujishima N; Yoshioka T; Sawada K
Int J Hematol; 2007 Oct; 86(3):291-2. PubMed ID: 17989001
[No Abstract] [Full Text] [Related]
19. Epstein-Barr virus infection triggering a haemophagocytic syndrome.
Olaya M; Alsina L; de Sevilla MF; Catalá A; López-Ramos MG; Martín Mateos MA; Plaza AM
Allergol Immunopathol (Madr); 2014; 42(6):627-9. PubMed ID: 24231151
[No Abstract] [Full Text] [Related]
20. Hemophagocytic lymphohistiocytosis in a patient with x-linked lymphoproliferative disease.
Bird JA; McClain KL; Rosenblatt HM; Abramson SL; Hanson IC
Allergy Asthma Proc; 2009; 30(4):458-62. PubMed ID: 19772767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
